Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-01-13 Sale | 2023-01-13 6:33 pm | Fulcrum Therapeutics Inc. | FULC | Gould Robert J Interim President & CEO | 6,766 | $15 | $101,490 | 499,864 (Direct) | View |
| 2022-06-07 Sale | 2022-06-08 7:33 pm | Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director | 71,435 | $8.0898 | $577,895 | 593,153 (Direct) | View |
| 2022-06-02 Sale | 2022-06-06 7:00 pm | Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director | 66,622 | $7.9975 | $532,810 | 1,054,819 (Direct) | View |
| 2022-04-07 Sale | 2022-04-11 5:00 pm | Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director | 5,631 | $24.02 | $135,228 | 731,210 (Direct) | View |
| 2022-04-01 Sale | 2022-04-05 7:00 pm | Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director | 94,251 | $24.16 | $2,276,684 | 1,309,602 (Direct) | View |
| 2021-03-15 Sale | 2021-03-17 4:30 pm | Fulcrum Therapeutics Inc. | FULC | Gould Robert J See Remarks | 10,000 | $12.16 | $121,578 | 506,630 (Direct) | View |
| 2021-02-16 Sale | 2021-02-18 4:30 pm | Fulcrum Therapeutics Inc. | FULC | Gould Robert J See Remarks | 8,215 | $14.27 | $117,197 | 516,630 (Direct) | View |
| 2021-01-20 Sale | 2021-01-22 4:30 pm | Fulcrum Therapeutics Inc. | FULC | Gould Robert J See Remarks | 10,000 | $12.08 | $120,826 | 524,845 (Direct) | View |
| 2020-07-08 Sale | 2020-07-09 4:15 pm | Fulcrum Therapeutics Inc. | FULC | Gould Robert J See Remarks | 2,500 | $20 | $50,000 | 534,845 (Direct) | View |
| 2020-06-25 Sale | 2020-06-26 4:15 pm | Fulcrum Therapeutics Inc. | FULC | Gould Robert J See Remarks | 2,500 | $20.8 | $51,992 | 537,345 (Direct) | View |
| 2020-06-09 Sale | 2020-06-10 4:15 pm | Fulcrum Therapeutics Inc. | FULC | Gould Robert J See Remarks | 156 | $20 | $3,120 | 539,845 (Direct) | View |
| 2020-06-05 Sale | 2020-06-09 4:16 pm | Fulcrum Therapeutics Inc. | FULC | Gould Robert J See Remarks | 3,433 | $20.17 | $69,251 | 540,001 (Direct) | View |
| 2020-06-03 Sale | 2020-06-05 4:26 pm | Fulcrum Therapeutics Inc. | FULC | Gould Robert J See Remarks | 2,800 | $20.09 | $56,250 | 543,434 (Direct) | View |
| 2020-06-01 Sale | 2020-06-03 4:17 pm | Fulcrum Therapeutics Inc. | FULC | Gould Robert J See Remarks | 2,802 | $20 | $56,040 | 546,234 (Direct) | View |
| 2020-05-28 Sale | 2020-06-01 4:15 pm | Fulcrum Therapeutics Inc. | FULC | Gould Robert J See Remarks | 3,309 | $20.04 | $66,302 | 549,036 (Direct) | View |
| 2020-05-26 Sale | 2020-05-28 4:15 pm | Fulcrum Therapeutics Inc. | FULC | Gould Robert J See Remarks | 2,500 | $20 | $50,000 | 552,345 (Direct) | View |
| 2020-02-19 Sale | 2020-02-20 4:24 pm | Fulcrum Therapeutics Inc. | FULC | Gould Robert J See Remarks | 2,500 | $20 | $50,000 | 554,845 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2023-07-20 9:50 pm | N/A 2029-06-09 | Turnstone Biologics Corp. | TSBX | Gould Robert J Director | 0 | $0 | 52,902 (Direct) | View |
| 2023-06-27 Option Award | 2023-06-29 4:16 pm | N/A 2033-06-26 | Fulcrum Therapeutics Inc. | FULC | Gould Robert J Interim President & CEO | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-06-27 Option Award | 2022-06-29 5:00 pm | N/A 2032-06-26 | Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director | 19,000 | $0 | 19,000 (Direct) | View |
| 2022-06-07 Exercise | 2022-06-08 7:33 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director | 71,435 | $7.84 | 593,153 (Direct) | View |
| 2022-06-07 Exercise | 2022-06-08 7:33 pm | N/A 2022-06-30 | Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director | 71,435 | $0 | 593,153 (Direct) | View |
| 2022-06-02 Exercise | 2022-06-06 7:00 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director | 66,622 | $7.84 | 1,054,819 (Direct) | View |
| 2022-06-02 Exercise | 2022-06-06 7:00 pm | N/A 2029-01-21 | Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director | 66,622 | $0 | 1,054,819 (Direct) | View |
| 2022-04-07 Exercise | 2022-04-11 5:00 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director | 5,631 | $7.84 | 731,210 (Direct) | View |
| 2022-04-07 Exercise | 2022-04-11 5:00 pm | N/A 2029-01-21 | Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director | 5,631 | $0 | 731,210 (Direct) | View |
| 2022-04-01 Exercise | 2022-04-05 7:00 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director | 94,251 | $7.84 | 1,309,602 (Direct) | View |
| 2022-04-01 Exercise | 2022-04-05 7:00 pm | N/A 2029-01-21 | Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director | 94,251 | $0 | 1,309,602 (Direct) | View |
| 2021-02-02 Option Award | 2021-02-04 4:35 pm | N/A 2031-02-01 | Fulcrum Therapeutics Inc. | FULC | Gould Robert J See Remarks | 269,390 | $0 | 269,390 (Direct) | View |
| 2020-01-23 Option Award | 2020-01-27 4:26 pm | N/A 2030-01-22 | Fulcrum Therapeutics Inc. | FULC | Gould Robert J President & CEO | 200,000 | $0 | 200,000 (Direct) | View |
| 2019-07-18 Option Award | 2019-07-18 5:27 pm | N/A 2029-07-17 | Fulcrum Therapeutics Inc. | FULC | Gould Robert J See Remarks 10% Owner | 107,142 | $0 | 107,142 (Direct) | View |
Ownership | 2019-07-17 7:37 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Gould Robert J See Remarks 10% Owner | 0 | $0 | 881,807 (Direct) | View |